RIA
PDLI

Realta Investment Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Realta Investment Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,000
Closed -$4K – 1879
2019
Q1 		$4K Buy
+1,000
New +$3.38K ﹤0.01% 1140

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Realta Investment Advisors's PDLI Position: Q2 2019 in Review

Realta Investment Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 1,000 shares — an estimated $4K sold.

Realta Investment Advisors first reported a position in PDLI in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

  • Realta Investment Advisors reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Realta Investment Advisors sold 1,000 PDL BioPharma, Inc. shares in Q2 2019, an estimated $4K.
  • Realta Investment Advisors first reported a position in PDL BioPharma, Inc. in Q1 2019 and held it in 1 quarter.
  • Realta Investment Advisors's PDL BioPharma, Inc. position peaked at $4K in Q1 2019.
  • 148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Realta Investment Advisors's 13F filing for Q2 2019, filed 1 Aug 2019.